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Abstract Glycosaminoglycans (GAGs) are polysaccharides
that are typically present in a wide diversity of animal tissue.
Most commonGAGs arewell-characterized and pharmaceutical
applications exist for many of these compounds, e.g. heparin
and hyaluronan. In addition, also bacterial glycosaminoglycan-
like structures exist. Some of these bacterial GAGs have been
characterized, but until now no bacterial GAG has been found
that possesses the modifications that are characteristic for many
of the animal GAGs such as sulfation and C5-epimerization.
Nevertheless, the latter conversion may also occur in bacterial
and archaeal GAGs, as some prokaryotic polysaccharides have
been demonstrated to contain L-iduronic acid. However,
experimental evidence for the enzymatic synthesis of L-
iduronic acid in prokaryotes is as yet lacking. We therefore
performed an in silico screen for D-glucuronyl C5-epimerases
in prokaryotes. Multiple candidate C5-epimerases were found,
suggesting that many more microorganisms are likely to exist
possessing an L-iduronic acid residue as constituent of their
cell wall polysaccharides.
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Introduction
Glycosaminoglycans (GAGs) are long linear negatively
charged hetero-polysaccharides, consisting of repeating
disaccharide residues usually of a hexuronic acid linked to
a hexosamine. Glycosaminoglycans are ubiquitously found
throughout the animal kingdom, where they are involved in
a wide variety of biological processes. The most common
glycosaminoglycans are chondroitin sulfate, dermatan
sulfate, heparan sulfate, heparin, hyaluronan and keratan
sulfate. An overview is given in Table 1.
The glycosaminoglycan hexuronic acid residue is either
D-glucuronic acid or its C5 epimer L-iduronic acid. The
latter is a rather unique hexuronic acid that is typically
found in glycosaminoglycans, while D-glucuronic acid is a
very common compound in nature. The epimerization of D-
glucuronic acid towards L-iduronic acid is mediated by a
D-glucuronyl C5-epimerase acting at a polysaccharide level
after D-glucuronic acid incorporation [1, 2]. The C5-
epimerization of D-glucuronic acid is essential for specific
binding properties of versatile glycosaminoglycans like
heparin and heparan sulfate. Another D-glucuronyl C5-
epimerase does exist responsible for dermatan sulfate
biosynthesis, as well as a C5-epimerase involved in alginate
biosynthesis. These epimerases do not show sequence
homology to the heparin D-glucuronyl C5-epimerase [3].
Glycosaminoglycans traditionally are isolated from
animal tissue. A major drawback is the great polydispersity
of animal-derived material, both in chain length and degree
of epimerization/sulfation. Large scale chemical synthesis
of heparin is not feasible, because of the C5-epimerization
of D-glucuronic acid being one of the major bottlenecks. L-
iduronic acid can be synthesized chemically, however C5-
epimerization of D-glucuronic acid as part of a polymer
only can be done enzymatically. In the past decades the C5-
epimerase in animal heparin biosynthesis has been identi-
fied and characterized [4], and has some major limitations
to use in large scale biotechnological production processes.
Novel D-glucuronyl C5-epimerases that have less restric-
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tions in substrate acceptance, better stability and easier
production methods would have great potential in con-
trolled chemo-enzymatic synthesis of L-iduronic acid
containing polymers like heparin and heparin-analogs. In
this review we discuss putative novel C5-epimerases that
might convert D-glucuronic acid to L-iduronic acid with
less restrictions.
Glycosaminoglycan-like structures in bacterial capsules
Traditionally, GAGs were considered as polymeric structures
only to be found in (in)vertebrate animals. However, in the
past decades, some polyanionic bacterial cell wall polysac-
charides have been described, of which the structure has
resemblance to some well-characterized animal glycosamino-
glycans. Microorganisms possessing GAGs generally are
pathogenic bacteria in which the surface exposed capsular
polysaccharides are likely to serve as a virulence factor. The
resemblance between the bacterial capsule and the animal
GAG results in very limited or no response of the hosts’
immune system. GAG-containing pathogens, including sero-
types of both Escherichia coli and Pasteurella multocida, are
discussed below.
E. coli GAGs Many different serotypes of E. coli have been
described. Discrimination between these strains is generally
based on antigenic studies. Mostly differences can be found
in a specific part of the bacterial lipopolysaccharide (LPS),
the so-called O-antigen. To a lesser extent differences are
seen in antigenic properties of the flagella (H-antigen) and
the bacterial capsule (K-antigen). The latter is a protective
layer of polysaccharides that generally can be easily
observed by light microscopy. Over 70 different K-
antigens have been described [5]. As discussed below,
two of them are analogous to glycosaminoglycans as found
in animals.
A chondroitin-like glycosaminoglycan has been isolated
from E. coli O5 : K4 : H4 [6]. Identical to chondroitin this
“K4 capsular polysaccharide” consists of equimolar
amounts of β-D-glucuronic acid and β-N-acetyl-galactos-
amine. Unlike chondroitin an additional fructose is β(1-3)
linked as a substituent to each GlcA residue. However, this
modification can easily be removed by mild acidification,
resulting in a chondroitin backbone. Upon removal of the
fructose residue, the immune response against the K4
polysaccharide decreases considerably.
Another glycosaminoglycan-like structure has been
described for the K5 antigen of E. coli O10 : K5 : H4.
This capsular polysaccharide has an identical structure to
heparosan, the unsulfated and non-epimerized backbone
structure of heparan sulfate and heparin. The K5 capsule is
a linear polysaccharide containing α-N-acetyl-glucosamine
and β-glucuronic acid in equimolar amounts, linked by an
(1-4) glycosidic bond [7]. In contrast to animals, no post-
polymerization modifications occur on the heparosan
molecule. This makes the K5 polysaccharide a useful
substrate to study the enzymes in heparin biosynthesis [8,
9], and a potential precursor for chemo-enzymatic synthesis
of heparin.
P. multocida GAGs Similar glycosaminoglycans have been
isolated from several serotypes of another pathogenic gamma-
proteobacterium, namely Pasteurella multocida. The capsules
of P. multocida type A, D and F could be removed upon
treatment with different glycosaminoglycan hydrolases [10].
A more detailed analysis of the capsular polysaccharides of
P. multocida type D and F has revealed similarity with the K-
antigens of E. coli K5 and K4 respectively. The P. multocida
type D polymer is identical to heparosan, the type F polymer
is unmodified chondroitin [11].
Additionally, another P. multocida capsular polysaccharide
has been described to be analogous to a vertebrate
glycosaminoglycan. The extracellular capsule of P. multocida
type A is chemically identical to the animal GAG hyaluronan
[12]. In addition, multiple species of Streptococci have been
described to have such a hyaluronan capsule. All these
strains are pathogenic to human or other mammals, the
hyaluronan capsule having an important role in preventing an
immune response. Since these molecules are identical to
Table 1 Overview of the most common glycosaminoglycans. GlcA, glucuronic acid; GalNAc, N-acetyl-galactosamine; GlcNAc, N-acetyl-
glucosamine; IdoA, iduronic acid; GlcNS, N-sulfate-glucosamine; Gal, galactose; C#, carbon number; ECM, extracellular matrix
Glycosaminoglycan Main disaccharide Sulfation pattern Localization
Chondroitin sulfate -4)GlcAβ(1-3)GalNAc-β(1- GalNAc at C4/C6 and GlcA at C2 cartilage, bone, heart valves
Dermatan sulfate -4)IdoAα(1-3)GalNAc-β(1- GalNAc at C4/C6 and IdoA at C2 skin, blood vessels, heart valves
Heparan sulfate -4)GlcAβ(1-4)GlcNAc-α(1- GlcA(IdoA) at C2, GlcNAc(NS) at C6, C3 cell surface membranes, ECM
Heparin -4)IdoAα(1-4)GlcNS-α(1- like heparan sulfate but heavier mast cells (e.g. lungs, liver, skin)
Hyaluronan -4)GlcAβ(1-3)GlcNAc-β(1- completely unsulfated synovial fluid, eye, ECM, skin
Keratan sulfate -3)Galβ(1-4)GlcNAc-β(1- Gal and GlcNAc at C6 cornea, bone, cartilage
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mammalian hyaluronan, bacterially produced hyaluronian
has substantial commercial value. In addition to animal
derived hyaluronan, it is nowadays widely commercially
available for numerous existing applications.
Although multiple examples of bacterial GAGs do exist,
for none of these glycosaminoglycans modifications have
been observed similar to those in the GAG biosynthesis
pathways in animals. A key modification step in these
pathways is the C5-epimerization of D-glucuronic acid
towards L-iduronic acid, catalyzed by a D-glucuronyl C5-
epimerase. No bacterial counterpart of this enzyme has
been experimentally characterized to date. However, the
presence of L-iduronic acid in extracellular polysaccharides
of several microorganisms, suggests that D-glucuronyl C5-
epimerases do exist in prokaryotes.
Identification of iduronic acid in microbes
While being a well-known component of (animal) glyco-
saminoglycans, the presence of L-iduronic acid in prokar-
yotes is rather uncommon. For some time it was believed
that L-iduronic acid could only be found in multicellular
eukaryotes. However, as discussed below, in the last
decades multiple examples of microbial L-iduronic acid
have been published.
Bacteria
The first case of L-iduronic acid being present in a prokaryote
was reported in a study of the gram-positive bacterium
Clostridium perfringens NCTC 10578 [13]. L-iduronic acid
was identified in a purified “type-specific” polysaccharide
from Clostridium perfringens strain Hobbs 10. The exact
polysaccharide structure is still unknown but the L-iduronic
acid level in the isolated polysaccharide is estimated to be
7%. Most likely this “type-specific” polysaccharide is part of
a bacterial capsular polysaccharide [14].
Another report on the presence of L-iduronic acid in a
prokaryote concerns the analysis of specific extracellular
polysaccharide (EPS) of Butyrivibrio fibrisolvens strain
X6C61 [15]. As much as 37 strains of B. fibrisolvens were
screened in total, but only a single strain appeared to
contain L-iduronic acid. This indicates that L-iduronic acid
is part of a type-specific EPS. The exact composition of the
EPS remains to be characterized, although it has been
proposed that L-iduronic acid is associated to a galactos-
amine residue.
In addition, several reports exist in which L-iduronic
acid is identified as a compound of an O-specific
polysaccharide. An O-antigen is the highly variable part
of a lipopolysaccharide (LPS), which is present in the outer
membrane of gram-negative bacteria. The first report of L-
iduronic acid being present in an O-antigen was after
structure elucidation of the O-antigen of the marine
bacterium Pseudoalteromonas haloplanktis strain KMM
223 (44-1) [16]. The L-iduronic acid residue is part of a
pentasaccharide (Fig. 1) that additionally contains two D-
glucuronic acid residues and two residues of the uncommon
QuiN4N (2,4-diamino-2,4,6-trideoxyglucose). The high
amount of hexuronic acids results in a highly acidic O-
antigen. In addition, the uncommon QuiN4N residues and
GlcA residues have been found in other serotypes of
Pseudoalteromonas [17], however strain KMM 223
remains the only example that has an L-iduronic acid-
containing O-antigen.
More recently, two additional O-antigens have been
identified in which L-iduronic acid is one of the building
blocks (Fig. 1). Both Escherichia coli type 112ab and
Shigella boydii B15, have an identical pentasaccharide
structure [18, 19]. Many more O-antigen structures of
various serotypes of both E. coli and S. boydii have been
resolved to date, however L-iduronic acid seems to be
restricted to these two reported strains. Just like the
previous reports dealing with L-iduronic acid identification
in bacteria, the occurrence of this structure is highly type-
specific rather than a general feature.
Archaea
L-iduronic acid has been reported in archaea only once. There
is evidence of the presence of iduronic acid in a cell surface
lipoprotein ofHalobacterium halobium [20]. The cell wall of
this archaeon is a glycoprotein based S-layer. The glycopro-
tein has two specific forms of N-glycosylation. First each
polypeptide consists of a single glycosaminoglycan-like
polysaccharide with a [-4)GalNAc(1-4)GalA(1-3)-GalNAc
(1-]n10–15 backbone attached. Apart from that, there are 12
potential glycosylation sites where an Asn-Glc (aspar-
aginylglucose) linkage unit is extended by two or three
β(1-4) bound glucuronic acid residues. About 1/3 of
these glucuronic acid moieties are replaced by an
iduronic acid (Fig. 1). An identical glycoconjugate can
be found at the organisms’ flagellin [21]. Although
archaeal flagellins often undergo posttranslational modifi-
cation [22], until now this is the only report of iduronic
acid presence in such a structure.
Non-canonical L-iduronic acid containing polymers
in eukaryotes
L-iduronic acid traditionally is considered to be a compo-
nent in many common animal glycosaminoglycans. Apart
from these well-characterized GAGs, recently L-iduronic
acid also has been identified in some atypical polymers.
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The eukaryotic organisms having these non-canonical
polymers usually do not possess the traditional GAGs as
found in animals. Possibly the formation of L-iduronic acid
is the result of another C5-epimerase than the heparosan D-
glucuronyl C5-epimerase. An overview of some of these
rare L-iduronic acid containing structures is provided
below.
Algae Pleurochrysis haptonemofera is a unicellular cocco-
lithophorid marine alga. It produces coccolith, a calcified
scale. Apart from carbonate crystals, this scale contains a
small amount of polysaccharide called “coccolith matrix
acidic polysaccharide” (CMAP). The structure of CMAP
has been determined to be composed of a repeating
disaccharide structure, of which L-iduronic acid is one of
the sugars [23]. In addition there are reports of the existence
of L-iduronic acid in specific polysaccharides in multicel-
lular algae. The cell wall of sea lettuce (genus Ulva)
includes four types of polysaccharides, of which the water-
soluble ulvan is exclusively found in members of the
Ulvales. This polysaccharide has a repetitive disaccharide
of L-iduronic acid that is α(1-4) linked to a C3-sulfated
rhamnose [24].
Fungi Phallic acids are specific glycuronans that can be
found in the fruiting-bodies of members of the taxon
Phallales. Tsuchihashi and colleagues have described the
isolation of phallic acid of at least ten species, all
containing L-iduronic acid. [25]. The exact structural
composition is still unknown, but it has been reported that
these polysaccharides are composed of β-glucuronic acid
and α-iduronic acid residues that have an (1-4) linkage. The
internal ratio of these two hexuronic acids varies around 2:1
to 3:1. The polysaccharide is called protuberic acid when
the ratio glucuronic acid to iduronic acid is equal to 2:1
[26].
Sponges Citronamides A and B are unique products that
have been isolated from the Australian sponge Citronia
astra. Both are non-canonical tetrapeptides with a linked 3-
or 4-O-(aminocarbonyl)-α-iduronic acid residue. These
compounds accidently have been co-isolated with Dysino-
sin A, a potential serine protease (thrombin) inhibitor.
Citronamides A and B are structurally not related to
Dysinosin A, and the biological function of these products
still needs to be clarified [27].
Identification of C5-epimerases in prokaryotes
The above described polymeric structures are examples
of L-iduronic acid containing polysaccharides and
glycosaminoglycan-like structures in several microorgan-
isms. The existence of L-iduronic acid does suggest D-
glucuronyl C5-epimerase activity to occur in these organisms.
The wide diversity of these GAG-like structures suggests the
presence of candidate C5-epimerases with a different or
broader substrate specificity. To date no such candidate
enzyme has been identified.
Fig. 1 Known prokaryotic structures containing L-iduronic acid;
bacterial O-antigens and the Halobacterium halobium glycoconjugate.
GlcA, glucuronic acid; QuiNHb4N, 2,4-diamino-2,4,6-trideoxy-D-
glucose (Hb, S-3-hydroxybutyryl; Ac, acetyl); IdoA, iduronic acid;
GlcNAc, N-acetyl-glucosamine; GalNAc, N-acetyl-galactosamine
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In an attempt to identify candidate C5-epimerases, we
screened all available prokaryotic genomes for sequences
homologous to human D-glucuronyl C5-epimerase by Blast
analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi) [28]. Mul-
tiple prokaryotic sequences were identified that have
homology to the human sequence. Also Blasts on meta-
genome data reveal multiple putative prokaryotic C5-
epimerases. All found candidate C5-epimerases have a
well-conserved domain making them members of the
pfam06662 superfamily [29] containing the consensus of
the C-terminus of D-glucuronyl C5-epimerases. An over-
view of all prokaryotes having one or more candidate D-
glucuronyl C5-epimerase gene(s) is provided in Table 2.
The occurrences of these candidate C5-epimerases seem
to be type-specific rather than species-specific. This is in
line with the earlier discussed reports on the identification
of L-iduronic acid containing polymers in prokaryotes, that
also appear to be type-specific in various species. Among
the identified candidate C5-epimerases differences in size
exist; however, this is mainly a result of variation of the N-
terminal domain of the protein. Most prokaryotic sequences
show a similar organization as the protein sequence of
animal D-glucuronyl C5-epimerases. An N-terminal signal
peptide is predicted for many sequences and at the C-
terminus of the protein the conserved pfam06662 domain
can be found. This architecture resembles that of animal D-
glucuronyl C5-epimerases. A multiple sequence alignment
of the C-terminal domain of the prokaryotic candidate C5-
epimerase and a selection of animal C5-epimerases is
included (Fig. 2). It is tempting to speculate on the role of
those amino acid residues that are completely conserved.
Residues possibly involved in catalysis are the conserved
tyrosines and histidines. Structural data of two other types
of C5-epimerases, not homologous to the heparin C5-
epimerase [3] and the prokaryotic candidate epimerases,
reveal a role of conserved histidines and tyrosines in
catalysis for both functionally distinct C5-epimerases [30,
31]. Although there is no homology at amino acid level, a
similar catalytic mechanism of the heparin-acting C5-
epimerase to these distinct C5-epimerases cannot be ruled
out and could be feasible.
We constructed a phylogenetic tree [32] containing
several eukaryotic D-glucuronyl C5-epimerases, as well as
a selection of prokaryotic homologs. The multiple sequence
alignment [33, 34] is mostly based on the C-terminus of the
genes (Fig. 2). No remarkable differences were observed
when constructing a tree of the full length sequences or of
the C-terminus only. Phylogenetically, the prokaryotic
candidate C5-epimerase sequences cluster in a domain-
specific way (Fig. 3). Most deviation is observed in
bacterial sequences, while archaea and eukaryotes are more
alike. Obvious inter-domain substitutions can not be
observed, and are not expected to have occurred recently.
Few bacterial sequences do cluster with eukaryotes and
archaea but these are close to the root and bootstrap values
are too low to draw any conclusions.
On an intra-domain level one could speculate on the
clustering. Considering a confidence level of 70% or
higher, the archaeal genes cluster in two clades.
Surprisingly the two Methanothermobacter species do
not cluster with the Methano(caldo)cocci. The subset of
bacterial sequences gives rise to several clades, each not
necessarily clustered in a class specific way. An example
is seen for Thermoanaerobacter, Bacillus and Rumino-
coccus that do cluster with Bacteroides and not cluster
with the clostridiae genes, even though they are all in the
class of firmicutes. Instead the clostridiae genes cluster
with an Acidobacterium. It is tempting to speculate that
these deviations reflect the occurrence of variant enzymes
(paralogs) with a different substrate specificity. This is
expected because of the wide diversity that exists in
bacterial cell wall polysaccharides. Most likely the
candidate C5-epimerases are involved in the biosynthesis
of type-specific polysaccharides.
The association of the putative candidate C5-epimerases
with other (predicted) sugar modifying enzymes (e.g.
glycosyltransferases) is clearly revealed upon neighborhood
analysis of the involved prokaryotic genomes (Fig. 4).
Genes in this gene cluster are likely to be involved in strain
specific O-antigen production [35], since some of the
sequences have homology to the wbb operon [36], which
is known to be involved in the O-antigen biosynthesis [37].
As LPS do not occur in gram positives, alternatively these
gene clusters can also be involved in the biosynthesis of a
capsular polysaccharide. This cell wall structure can occur
in gram positive bacteria like T. tengcongensis. The exact
gene function is hard to distinguish, since genes involved in
polysaccharide capsule biosynthesis are sometimes embed-
ded in the other cell wall biosynthesis related gene regions
(e.g. LPS) and vice versa [38].
A remarkable similarity in genomic organization is seen
for some of the putative C5-epimerases. Figure 4 shows the
flanking genes up- and downstream the candidate C5-
epimerases of two Vibrio cholerae strains (albensis VL426
and CO845), the thermophilic bacterium Thermoanaero-
bacter tengcongensis MB4 and two Photorhabdus species.
Both Photorhabdus luminescens TT01 and Photorhabdus
asymbiotica are symbiotic pathogens of insects, although P.
asymbiotica is occasionally found as an opportunistic
pathogen of humans as well. V. cholera is a well-known
human pathogen, causing cholera. No virulence activity is
reported for T. tengcongensis [39].
For most of these prokaryotic candidate C5-epimerases,
the gene is in close proximity of various sugar modifying
enzymes. The analogy in gene neighborhood organization
is remarkably similar for the above mentioned five bacteria.
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Table 2 Overview candidate C5-epimerases in prokaryotes
Organism Class Size Gene ID e-value..
Bacteria; Acidobacteria
Candidatus Koribacter versatilis Ellin345 Candidatus koribacter 401 aa 94970543 9e–65
Bacteria; Actinobacteria
Sanguibacter keddieii DSM 10542 Actinobacteridae 355 aa 269795908 1e–16
Conexibacter woesei DSM 14684 Rubrobacteridae 473 aa 284043115 3e–19
Conexibacter woesei DSM 14684 Rubrobacteridae 489 aa 284046741 1e–26
Bacteria; Bacteroidetes
Bacteroides sp. 1_1_6 Bacteroidia 305 aa 253567783 1e–29
Bacteria; Firmicutes
Bacillus cereus R309803 Bacillales 307 aa 229164211 2e–40
Clostridium ljungdahlii ATCC 49587 Clostridia 737 aa 300854052 6e–52
Clostridium ljungdahlii ATCC 49587 Clostridia 399 aa 300855735 9e–53
Clostridium ljungdahlii ATCC 49587 Clostridia 372 aa 300855857 7e–50
Clostridium kluyveri DSM 555 Clostridia 411 aa 153953040 1e–35
Clostridium kluyveri DSM 555 Clostridia 372 aa 153953635 2e–32
Clostridium kluyveri DSM 555 Clostridia 452 aa 153953720 1e–32
Clostridium kluyveri NBRC 12016 Clostridia 414 aa 219853696 1e–35
Ruminococcus sp. 18P13 Clostridia 302 aa 291544017 6e–34
Thermoanaerobacter tengcongensis MB4 Clostridia 312 aa 20807150 3e–58
Bacteria; Proteobacteria
Campylobacter hominis ATCC BAA-381 Epsilonproteobacteria 458 aa 154149157 4e–34
Nautilia profundicola AmH Epsilonproteobacteria 317 aa 224373665 2e–38
Bermanella marisrubri sp. RED65 Gammaproteobacteria 448 aa 94501207 2e–76
Escherichia coli O112ab Gammaproteobacteria 323 aa 187880578 1e–23
Shigella boydii type 15 Gammaproteobacteria 323 aa 187880569 1e–23
Photorhabdus asymbiotica Gammaproteobacteria 370 aa 253991788 5e–15
Photorhabdus luminescens sp. laumondii TTO1 Gammaproteobacteria 368 aa 37528614 4e–12
Vibrio cholerae bv. albensis VL426 Gammaproteobacteria 308 aa 229524794 2e–27
Vibrio cholerae st. CO845 Gammaproteobacteria 311 aa 295149004 9e–34
Archaea; Korarchaeota
Candidatus Korarchaeum cryptofilum OPF8 Candidatus korarchaeum 337 aa 170290161 3e–28
Archaea; Euryarchaeota
Methanothermobacter marburgensis st Marburg Methanobacteria 381 aa 304314521 8e–40
Methanothermobacter thermautotrophicus ΔH Methanobacteria 405 aa 15678358 2e–59
Methanocaldococcus fervens AG86 Methanococci 305 aa 241911015 5e–59
Methanocaldococcus infernus ME Methanococci 298 aa 241904910 6e–48
Methanocaldococcus jannaschii DSM 2661 Methanococci 308 aa 15669315 5e–61
Methanocaldococcus vulcanius M7 Methanococci 305 aa 255051598 2e–51
Methanococcus voltae A3 Methanococci 330 aa 163798575 7e–10
Thermococcus barophilus MP Thermococci 367 aa 197628867 3e–22
Thermococcus barophilus MP Thermococci 511 aa 197629016 3e–33
Thermococcus onnurineus NA1 Thermococci 520 aa 212224590 3e–32
Thermococcus sibiricus MM 739 Thermococci 371 aa 242398189 2e–27
Thermococcus sibiricus MM 739 Thermococci 512 aa 242398190 9e–35
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Fig. 2 Multiple sequence
alignment of C-terminal part of
the candidate D-glucuronyl
C5-epimerases. The positions of
the first and last residues of the
aligned region of the
corresponding candidate
C5-epimerase are indicated for
each sequence. Names are
abbreviated and in the same
order as in Fig. 3
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Fig. 4 Neighborhood analysis candidate C5-epimerases
Fig. 3 Phylogenetic analysis candidate C5-epimerases. The coloring of branches is domain specific; eukarya in red, bacteria in blue and archaea
in green. The used bootstrap value is 1000
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Other bacterial candidate C5-epimerases have a different
organization of their gene neighborhood, despite the fact
that they are more related to any of these five species with
respect to taxonomy or candidate C5-epimerases sequence
identity. A clear example is seen for the candidate C5-
epimerase of Bacillus cereus R309803. This sequence is the
best hit compared to T. tengcongensis (54% identity, 70%
similarity). The homology of the T. tengcongensis sequence
to the putative C5-epimerases from Photorhabdus (wblE) is
rather low (15% identity, 31% similarity). Homology with
V. cholera is better (23% identity, 44% similarity), but still
weak compared to the best hit.
Naturally, addition of more sequences would give a better
understanding of the exact sequence distribution and a better
view on the number of different clades existing. However, it is
obvious that within this subset of sequences a clustering in
different clades exists, which is not necessarily class-specific.
An explanation of this phylogenetic distribution might be the
existence of several C5-epimerase paralogs. Given the
enormous variety in type-specific cell wall polysaccharides,
it is expected that enzymes involved in biosynthesis have a
substrate optimized specificity. Variations in substrate speci-
ficity of involved D-glucuronyl C5-epimerase would certainly
be feasible.
Conclusions
The C5-epimerization of D-glucuronic acid to its C5-
epimer L-iduronic acid has long been considered typical
for animal derived glycosaminoglycans. However, an
increasing number of L-iduronic acid containing structures
in microorganisms can be confidently identified in prokar-
yotes as well. Moreover, we found multiple candidate D-
glucuronyl C5-epimerases in a wide variety of microbes by
in silico analysis of available prokaryotic genome data.
Gene neighborhood analysis of these sequences suggests a
role in sugar modification, most likely in type-specific
polysaccharides (e.g. capsule polysaccharides or O-
antigens). Phylogenetic analysis indicates sub-clustering
of the set of candidate D-glucuronyl C5-epimerases into
several clades. This possibly correlates with the existence
of different C5-epimerase paralogs each having a distinct
substrate specificity. The exact physiological function
and substrate specificity requires biochemical analysis.
However, this subset of sequences and Blast analysis of
metagenomes reveal the existence of multiple candidate
C5-epimerase genes in prokaryotes, supporting the
conclusion that L-iduronic acid most likely is less rare
in prokaryotes than expected. These putative C5-
epimerases potentially may become important tools in
controlled chemo-enzymatic synthesis of L-iduronic acid
containing polymers like heparin and heparin-analogs.
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